Creative Medical TechnologyCELZ
13F holders, Q4 2025 (December 31)14holders +2
5new positions
3sold out
1famous investor
$1.96avg. 13F price*
At the end of Q4 2025, 14 institutions reported holding Creative Medical Technology (CELZ) in their 13F filings, up 2 from Q3 2025. 5 opened new positions and 3 sold out. The largest holders were Jane Street Group, LLC ($59K), Geode Capital Management, LLC ($56K) and Vanguard Group Inc. ($51K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Creative Medical Technology
- CUSIP
- 22529Y408
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $113K |
| Exits | 3 | $17K |
All 13F filers, Q3 2025 → Q4 2025: 68,120 shares bought and 9,982 shares sold, net +58,138 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Jane Street Group, LLC | 0.00% | New | 30,205 | $59K |
| Geode Capital Management, LLC | 0.00% | Add +22.4% | 28,467 | $56K |
| Vanguard Group Inc. | 0.00% | No change | 25,868 | $51K |
| Citadel Advisors | 0.00% | New | 17,460 | $34K |
| DRW Securities, LLC | 0.00% | Reduce -31.7% | 10,319 | $20K |
| Global Retirement Partners, LLC | 0.00% | New | 7,918 | $16K |
| Bank of America Corp. | 0.00% | Add +3817.6% | 5,132 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,315 | $5K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,130 | $2K |
| Morgan Stanley | 0.00% | No change | 34 | $67 |
| UBS Group AG | 0.00% | Add +450.0% | 11 | $22 |
| SBI Securities Co., Ltd. | 0.00% | No change | 1 | $2 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 1 | $2 |
| Motiv8 Investments LLC | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is CELZ's weight in each manager's 13F, not the share of Creative Medical Technology the manager owns.